Product Description
Top Features for Recombinant Transforming Growth Factor-beta 1:
Optimal use of expansion of HSC's
ADCF Level 2
High purity to ensure the safety of your process
Available in two different grades (Preclinical and GMP grade)
CellGenix® Recombinant Human Transforming Growth Factor-beta 1 (TGF-β1) is an animal-derived component-free product. It is produced in a dedicated GMP facility. TGF-β1 is used in the cell and gene therapy space to promote expansion of induced pluripotent stem cells (iPSCs), embryonic stem cells (ESCs), mesenchymal stem cells (MSCs) and regulatory T cells (Tregs).
CellGenix® Recombinant Human TGF-β1 is produced using a human amniocyte cell line (CAP®) to enable authentic human post-translational modifications.CAP® is a registered trademark of CEVEC Pharmaceuticals GmbH, Germany.
GMP grade: CellGenix® Recombinant Human TGF-β1 is produced following applicable GMP guidelines and allows for the safe use in accordance with USP Chapter <1043>, Ph. Eur. General Chapter 5.2.12 and ISO 20399:2022.
CellGenix® GMP cytokines are provided with documented evidence of purity, potency, consistency and stability. In combination with our expert regulatory and technical support this will help simplify your raw material qualification and validation efforts.
Expiry: ≥ 6 months from date of shipping.
We have submitted Drug Master Files (DMFs) to US Health Authorities to support our customers’ regulatory activities. These Master Files can be cross-referenced through Letters of Authorization (LOAs) in Marketing Authorizations, IND, BLA, NDA, ANDA or other DMF applications. Please submit your Authorization Request via the form above.
Preclinical grade: Designed to meet the demands of translational research, CellGenix® Preclinical cytokines are ideal to bridge the gap between the lower quality of research grade and the higher costs of GMP grade materials.
Expiry: 3 years from date of shipping
For the exact expiry date and the batch specific activity, please refer to the Certificate of Analysis on the My Sartorius Portal.
Safety Data Sheets (SDSs) are available on request.
Specifications
Applications:
Application Area: Cell & gene therapy; Immunology; Neuroscience
Cell Type: MSC; ESC/iPSC; T Cells; Organoids
Intended Use: For further manufacturing use
Biological Information:
Activity: 9 – 36 x 106 IU/mg
Compliance Information:
GMP Compliance: This product was manufactured in accordance with applicable Good Manufacturing Practice (GMP) guidelines.
Origin: Animal-Component Free
Quality Grade: GMP
Features:
Carrier-Protein Free: Yes
Physicochemical Information:
Endotoxin: ≤ 0.010 EU/µg
Expression System: CAP® cell line
Formulation: Lyophilized from a 0.2 µm-filtered solution containing 1% mannitol
Product Information:
Brand: CellGenix®
Package Type: Vial
Size: 50 µg
Sterility/Purity:
Delivery Condition: Sterile
Purity: ≥ 97%
Weight:
Molecular Weight (kDa): 25.6 kDa
Order Guidelines
1. Price & Stock Available on Request. Click to send email to: service@iright.com
2. Please DO NOT make payment before confirmtaion.
3. Minimum order value of $1,000 USD required.
4. 100% prepayment required.
Collaboration
Tony Tang
Email: Tony.Tang@iright.com
Mobile/WhatsApp/Wechat: +86-17717886924